Patent Opposition Database

Hide annotations

No Annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): 7440/DELNP/2015
Who filed: Sankalp Rehabilitation Trust
Country: India
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 06-09-2021
Patent type: Molecules

Add an annotation

Where in the document

Click within the document, or manually enter the page number below

9 similar patent oppositions

Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017010006)

Countries: India Date: 2021
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017007904)

Countries: India Date: 2021
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202018020805)

Countries: India Date: 2021
Sankalp Rehabilitation Trust opposition, Tofacitinib, (8222/DELNP/2015)

Countries: India Date: 2021
Sankalp Rehabilitation Trust opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)

Countries: India Date: 2015
Sankalp Rehabilitation Trust opposition, Rilpivirine, (2110/MUMNP/2013)

Countries: India Date: 2020
Sankalp Rehabilitation Trust opposition, Elsulfavirine, (1576/CHENP/2011)

Countries: India Date: 2022
Sankalp Rehabilitation Trust (Sankalp Trust), Mumbai opposition, Cabotegravir, (637/KOLNP/2013)

Countries: India Date: 2019
Hepatitis Coalition, Nagaland (HepCon), Sankalp Rehabilitation Trust (Sankalp Trust), Mumbai and Asia Pacific Network of Positive People (APN+), all of whom are represented by the Lawyers Collective opposition, daclatasvir, (853/DELNP/2009)

Countries: India Date: 2015